Harnessing massively parallel sequencing in personalized head and neck oncology

Journal of Dental Research

Volumn 93, Issue 5, 2014, Pages 437-444

  Jessri, M ^a,b   Farah, C S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

deep sequencing; DNA sequencing; head and neck neoplasms; high throughput nucleotide sequencing; individualized medicine; squamous cell carcinoma of the head and neck

Indexed keywords

TRANSCRIPTOME;

ARTICLE; DEEP SEQUENCING; DNA SEQUENCE; ETHICS; GENE EXPRESSION PROFILING; GENETICS; HEAD AND NECK TUMOR; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; METHODOLOGY; PERSONALIZED MEDICINE; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK;

DEEP SEQUENCING; DNA SEQUENCING; HEAD AND NECK NEOPLASMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; INDIVIDUALIZED MEDICINE; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDIVIDUALIZED MEDICINE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 84898952678     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514524783     Document Type: Article

References (59)

1. Agarwal A, Koppstein D, Rozowsky J, Sboner A, Habegger L, Hillier LW, et al. Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays. BMC Genomics. 2010 ; 11: 383
2. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011 ; 333 (6046). 1154-1157
3. Baxi S, Fury M, Ganly I, Rao S, Pfister DG. Ten years of progress in head and neck cancers. J Natl Compr Canc Netw. 2012 ; 10: 806-810
4. Brakenhoff RH. Another NOTCH for cancer. Science. 2011 ; 333: 1102-1103
5. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011 ; 364: 2507-2516
6. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009 ; 15: 6758-6762
7. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004 ; 5: 489-500
8. Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck. 2008 ; 30: 75-84
9. Desmedt C, Voet T, Sotiriou C, Campbell PJ. Next-generation sequencing in breast cancer: first take home messages. Curr Opin Oncol. 2012 ; 24: 597-604
10. Dotto GP. Notch tumor suppressor function. Oncogene. 2008 ; 27: 5115-5123
11. Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009 ; 323: 133-138
12. Ellis MJ, Perou CM. The genomic landscape of breast cancer as a therapeutic roadmap. Cancer Discov. 2013 ; 3: 27-34
13. Farah CS, Bhatia N, John K, Lee BW. Minimum intervention dentistry in oral medicine. Aust Dent J. 2013 ; 58: 85-94
14. Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011 ; 117: 915-919
15. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009 ; 361: 123-134
16. Garcia I, Kuska R, Somerman MJ. Expanding the foundation for personalized medicine: implications and challenges for dentistry. J Dent Res. 2013 ; 92: 3S - 10S
17. Glenn TC. Field guide to next-generation DNA sequencers. Mol Ecol Resour. 2011 ; 11: 759-769
18. Guo G, Gui Y, Gao S, Tang A, Hu X, Huang Y, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet. 2011 ; 44: 17-19
19. Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Lee KH, et al. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS ONE. 2013 ; 8: e64271
20. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 ; 100: 57-70
21. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 ; 144: 646-674
22. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. J Natl Cancer Inst. 2007 ; 99: 777-789
23. Hou L, Faraci G, Chen DTW, Kassem L, Schulze TG, Shugart YY, et al. Amish revisited: next-generation sequencing studies of psychiatric disorders among the Plain People. Trends Genet. 2013 ; 29: 412-418
24. Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, et al. Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis. J Clin Oncol. 2012 ; 30: 1996-2004
25. Jessri M, Farah CS. Next generation sequencing and its application in deciphering head and neck cancer. Oral Oncol. 2014 in press ;:
26. Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 2010 ; 11: R82
27. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol. 2008 ; 215: 145-154
28. Kamphans T, Sabri P, Zhu N, Heinrich V, Mundlos S, Robinson PN, et al. Filtering for compound heterozygous sequence variants in non-consanguineous pedigrees. PLoS ONE. 2013 ; 8: e70151
29. Kaye J, Boddington P, De Vries J, Hawkins N, Melham K. Ethical implications of the use of whole genome methods in medical research. Eur J Hum Genet. 2010 ; 18: 398-403
30. Kerick M, Isau M, Timmermann B, Sültmann H, Herwig R, Krobitsch S, et al. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics. 2011 ; 4: 68
31. Knoppers BM, Joly Y, Simard J, Durocher F. The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet. 2006 ; 14: 1170-1178
32. Liang XH, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: The Mayo Clinic experience. J Oral Maxillofac Surg. 2008 ; 66: 1875-1880
33. Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012 ; 2012: 251364
34. Mahjabeen I, Baig RM, Masood N, Sabir M, Inayat U, Malik FA, et al. Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res. 2012 ; 19: 183-188
35. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet. 2006 ; 38: 468-473
36. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet. 2008 ; 9: 387-402
37. Mardis ER. Applying next-generation sequencing to pancreatic cancer treatment. Nat Rev Gastroenterol Hepatol. 2012 ; 9: 477-486
38. Meldrum C, Doyle MA, Tothill RW. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev. 2011 ; 32: 177-195
39. Menon R, Deng M, Boehm D, Braun M, Fend F, Boehm D, et al. Exome enrichment and SOLiD sequencing of formalin fixed paraffin embedded (FFPE) prostate cancer tissue. Int J Mol Sci. 2012 ; 13: 8933-8942
40. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009 ; 361: 947-957
41. Morin RD, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh TJ, et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. BioTechniques. 2008 ; 45: 81-94
42. Mroz EA, Rocco JW. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol. 2012 ; 49: 211-215
43. Park SY, Gönen M, Kim HJ, Michor F, Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest. 2010 ; 120: 636-644
44. Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012 ; 13: 341
45. Rapaport F, Khanin R, Liang Y, Pirun M, Krek A, Zumbo P, et al. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol. 2013 ; 14: R95
46. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA, et al. Genetic structure of human populations. Science. 2002 ; 298: 2381-2385
47. Ross JS, Cronin M. Whole cancer genome sequencing by next-generation methods. Am J Clin Pathol. 2011 ; 136: 527-539
48. Ross JS, Torres-Mora J, Wagle N, Jennings TA, Jones DM. Biomarker-based prediction of response to therapy for colorectal cancer: current perspective. Am J Clin Pathol. 2010 ; 134: 478-490
49. Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011 ; 3: 111ra121
50. Rusk N. Torrents of sequence. Nat Methods. 2011 ; 8: 44
51. Salleh MZ, Teh LK, Lee LS, Ismet RI, Patowary A, Joshi K, et al. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine. PLoS ONE. 2013 ; 8: e71554
52. Schäfer SC, Pfnür M, Yerly S, Fandel TM, Jichlinski P, Lehr HA. Cryopreservation of prostate cancer tissue during routine processing of fresh unfixed prostatectomy specimen: demonstration and validation of a new technique. Prostate. 2009 ; 69: 191-197
53. Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, et al. RAD51C - a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncol. 2014 ; 50: 196-199
54. Schweiger MR, Kerick M, Timmermann B, Isau M. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations. Cancer Metastasis Rev. 2011 ; 30: 199-210
55. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011 ; 333: 1157-1160
56. Ulahannan D, Kovac MB, Mulholland PJ, Cazier JB, Tomlinson I. Technical and implementation issues in using next-generation sequencing of cancers in clinical practice. Br J Cancer. 2013 ; 109: 827-835
57. Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med. 2012 ; 14: 361-384
58. Ziogas DE, Katsios CS, Tzaphlidou M, Roukos DH. Targeted therapy: overcoming drug resistance with clinical cancer genome. Expert Rev Anticancer Ther. 2012 ; 12: 861-864
59. Zonta MA, Monteiro J, Santos G, Pignatari AC. Oral infection by the human papilloma virus in women with cervical lesions at a prison in São Paulo, Brazil. Braz J Otorhinolaryngol. 2012 ; 78: 66-72